Lilly Adds Two More Humalog Authorized Generics As Insurance Deductibles Reset

14 Jan 2020

With rebate reform efforts stalled, insulin manufacturer broadens efforts to lower prices through authorized generics, but PBMs may still like the big rebates they can get on the original brands.

Eli Lilly & Co. will introduce two new authorized generic versions of its Humalog KwikPens (insulin lispro) in April as it grapples with ongoing public criticism over the price of its flagship insulin brand.

The launch comes as patients in high deductible insurance plans face paying the full list price for insulin as their...